South Korea Car-T Cell Therapy Market is driven by immunotherapy...

Ajouter une nouvelle offre d'emploi Health

2025-05-16 12:15:13 -

South Korea Car-T Cell Therapy Market is driven by immunotherapy adoption

Chimeric antigen receptor T-cell (Car-T) therapy represents a breakthrough immunotherapy that engineers a patient’s own T cells to target and eliminate cancer cells. In South Korea, this advanced biologic treatment is gaining traction among oncologists due to its high remission rates in hematological malignancies, personalized approach, and potential to reduce relapse. Car-T cell...

0 Commentaires 0 Parts 603 Vue 0 Aperçu